NCT05405387 2026-03-20
IMPACT
University of Utah
Phase 2 Recruiting
Clinical Trials
10 trialsNCT04294641 2026-01-23
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT02400476 2022-05-06
An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
Puma Biotechnology, Inc.
Phase 2 Completed
NCT03369847 2019-07-18
Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge
New York City Health and Hospitals Corporation
Phase 4 Completed
NCT00321893 2016-01-25
Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT02504801 2015-07-22
Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD
Xuanwu Hospital, Beijing
Phase 4 Unknown
NCT00569712 2012-03-09
Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol
British Columbia Cancer Agency
Phase 1 Completed
NCT00646516 2011-01-24
Gemini Symbicort pMDI
AstraZeneca
Phase 3 Completed
NCT00180089 2010-03-30
Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation
Technische Universität Dresden
Phase 3 Completed
NCT00005880 2008-07-24
Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia
National Cancer Institute (NCI)
Phase 2 Completed